Shattuck Labs Inc (STTK) Option Chain

Tracking the STTK option chain helps you see every strike and expiry on Shattuck Labs Inc in one view, so you can quickly identify the contracts that fit your thesis and your risk. Shattuck Labs Inc's option chain lays out bids, asks, volume, open interest, and Greeks across calls and puts, giving you the full map of STTK options activity at a glance. Use our scanner to monitor the STTK option chain in real time and filter for the STTK options trades that actually meet your criteria.

An option chain is the complete listing of all available option contracts on an underlying, organized by expiration date and strike price. For STTK stock options, the chain shows side-by-side call and put data, making it easy to compare premiums, assess liquidity, and spot pricing dislocations. Reading the STTK option chain effectively means looking beyond the last price — implied volatility by strike, volume-to-open-interest ratios, and bid-ask spreads all tell you where STTK stock options are being actively traded and where they are not.

Shattuck Labs, Inc., a clinical-stage biotechnology company, develops therapeutics for the treatment of cancer and autoimmune disease in the United States. The company's lead product candidate is SL-172154, which is in Phase 1 clinical trial for the treatment of ovarian, fallopian tube, and peritoneal cancers. It also develops SL-279252 that is in Phase 1 clinical trial in patients with advanced solid tumors and lymphoma. The company was incorporated in 2016 and is headquartered in Austin, Texas.

Credit spreads, long calls, iron condors, calendar trades — every strategy starts with the same raw material: a clean, complete option chain. Our scanner pulls Shattuck Labs Inc's full chain across every expiry, highlights the most liquid strikes, and lets you screen STTK options by the metrics that matter, from IV skew to volume surges. Stop scrolling through endless rows of STTK stock options — let the full option chain come to you, pre-filtered and ready to trade.